MAPKAPK5 and prostate neoplasm: Our bioinformatic study also suggested a correlation of TLK1 and MK5 expression with the aggressiveness of prostate tumours, which hints towards a clinical relevance of TLK1‐MK5 signalling in PCa metastasis.